This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic Insulitis

List of authors.
  • Gian Franco Bottazzo, M.D., M.R.C.P., M.R.C.Path.,
  • Betty M. Dean, Ph.D.,
  • Jessica M. McNally,
  • E. Hugh MacKay, M.R.C.Path.,
  • Peter G.F. Swift, M.A., F.R.C.P., D.Ch.,
  • and D. Robert Gamble, F.R.C.Path.

Abstract

After the death of a 12-year old girl with newly discovered insulin-dependent diabetes mellitus, we used monoclonal antibodies in an effort to identify the cells invading the pancreas. The majority of infiltrating lymphocytes were of the T cytotoxic/suppressor phenotype, but other T-cell subpopulations were present. Some of the T cells were "activated" (positive for HLA-DR antigen, and the interleukin-2 receptor). Immunocytes bearing IgG were scattered in the gland, and complement-fixing IgG antibodies were deposited in some islets. Increased expression of Class I (HLA-A, B, and C) molecules was observed in the affected islet cells, and in damaged islets showing scant lymphocytic infiltration, some beta cells (still producing insulin), but not glucagon or somatostatin cells, were HLA-DR positive. The capillary endothelium was markedly dilated and strongly HLA-DR positive. These findings may contribute to an understanding of the sequence of events leading to the destruction of beta cells in classic Type I diabetes mellitus. (N Engl J Med 1985; 313:353)

Funding and Disclosures

Supported by the Medical Research Council, the Wellcome Trust Foundation, the British Diabetic Association, the Juvenile Diabetes Foundation (U.S.A..) the Joint Research Board of St. Bartholomew's Hospital, and Novo Research Laboratories (Copenhagen).

We are indebted to the scientists and commercial firms listed in Table 2 for their generous donations of monoclonal antibodies, to Professor Israel Doniach for his invaluable expertise in the histologic and immunocytochemical evaluations of the pancreatic sections, to Professor Deborah Doniach for her constructive suggestions and helpful discussion, to Professor I.M. Roitt for his constant support, and to Ms. C. McLean and Ms. M. Clark for their help in the preparation of the manuscript.

Author Affiliations

From the Department of Immunology, Middlesex Hospital Medical School, London, the Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital Medical School, London, the Departments of Pathology and Pediatrics, Leicester General Hospital, Leicester, and the Public Health Laboratory, West Park Hospital, Epsom, United Kingdom. Address reprint requests to Dr. Bottazzo at Middlesex Hospital Medical School, Department of Immunology, Arthur Stanley House, 40–50 Tottenham St., London W1P 9PG, England.

Print Subscriber? Activate your online access.